Alembic gains on share buyback plan
The stock up 7% to Rs 63.20 on BSE in intra-day trade after the pharmaceutical company announced that its board will consider share buyback proposal on Tuesday, January 23, 2018.
 "Alembic gains on share buyback plan")
premium
Alembic rallied 7% to Rs 63.20 on BSE in intra-day trade after the pharmaceutical company announced that its board will consider share buyback proposal on Tuesday, January 23, 2018.
“The board of directors of the company also consider and approve, the proposal for buy-back of fully paid-up equity shares of the Company, which would include maximum amount, maximum number of equity shares, mode of buy-back and other matters incidental thereto,” Alembic said in a regulatory filing.
Earlier, on January 12, 2018, the company said that a meeting of the board of directors of the company is scheduled to be held on January 23, 2018 to consider and approve the standalone financial statement for the quarter and nine months period ended 31st December, 2017.
As of December 2017, the promoters hold 63.71% stake in Alembic. Individual shareholders held 24.6% holding, followed by bodies corporate (3.25%), mutual funds (2.15%) and foreign portfolio investors (1.61%).
In past one month, the stock outperformed the market by surging 30% against 4.7% rise in the S&P BSE Sensex.
“The board of directors of the company also consider and approve, the proposal for buy-back of fully paid-up equity shares of the Company, which would include maximum amount, maximum number of equity shares, mode of buy-back and other matters incidental thereto,” Alembic said in a regulatory filing.
Earlier, on January 12, 2018, the company said that a meeting of the board of directors of the company is scheduled to be held on January 23, 2018 to consider and approve the standalone financial statement for the quarter and nine months period ended 31st December, 2017.
As of December 2017, the promoters hold 63.71% stake in Alembic. Individual shareholders held 24.6% holding, followed by bodies corporate (3.25%), mutual funds (2.15%) and foreign portfolio investors (1.61%).
In past one month, the stock outperformed the market by surging 30% against 4.7% rise in the S&P BSE Sensex.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%